|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash interest charges | |||||
| Provisions for losses on trade and other accounts receivable | |||||
| Gains on sales/disposals of operating property | |||||
| Impairment of intangible and other assets | |||||
| Deferred income taxes, net | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| (Increase) decrease in trade and other accounts receivable | |||||
| Increase in other assets | |||||
| Decrease in accounts payable | |||||
| (Decrease) increase in other liabilities | |||||
| Increase (decrease) in insurance claims | |||||
| NET CASH PROVIDED BY OPERATING ACTIVITIES | |||||
| INVESTING ACTIVITIES | |||||
| Sales and maturities of investments | |||||
| Purchases of investments | |||||
| Purchases of operating property | |||||
| Proceeds from sales of operating property | |||||
| Purchase of non-marketable securities | |||||
| NET CASH USED BY INVESTING ACTIVITIES | |||||
| FINANCING ACTIVITIES | |||||
| Decrease in cash overdraft | |||||
| Dividends paid | |||||
| Payment for debt issue costs | |||||
| Proceeds from exercises of stock options | |||||
| Taxes paid in lieu of shares issued related to stock-based compensation plans | |||||
| Purchases of common stock | |||||
| Principal payments on finance lease obligations | |||||
| Payment of deferred consideration | |||||
| NET CASH USED BY FINANCING ACTIVITIES | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| (Decrease) increase in cash and cash equivalents, including cash and cash equivalents classified as assets held for sale | |||||
| Less: Net change in cash and cash equivalents classified as assets held for sale | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...